ODI Pharma
1.69 SEK
0.00 %
Less than 1K followers
ODI
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
0.00 %
+21.58 %
+6.29 %
-11.05 %
-23.87 %
-43.67 %
-66.07 %
-67.12 %
-84.95 %
ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are made through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. Operations are found within the European market, with the headquarters in Stockholm.
Read moreMarket cap
30.98M SEK
Turnover
10K SEK
Revenue
3.11M
EBIT %
-168.49 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Interim report Q2'26
28.5
2026
Interim report Q3'26
27.8
2026
Annual report '26
All
Press releases
ShowingAll content types
ODI Pharma: Publication of interim report Q1 2025/2026
ODI Pharma demonstrates clear operational progress and improved commercial outlook
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools